Kunte Christian, Erlenkeuser-Uebelhoer Istrid, Michelsen Silke, Scheerer-Dhungel Karla, Plewig Gerd
Klinikum der Ludwig-Maximilians-Universität München, Klinik und Poliklinik für Dermatologie und Allergologie, Frauenlobstrasse 9-11, D-80337 Munich, Germany.
J Dtsch Dermatol Ges. 2005 Nov;3(11):889-94. doi: 10.1111/j.1610-0387.2005.05759.x.
Erosive, oral lichen planus is typically therapy-resistant. Histologically and immunopathologically there are many similarities between lichen planus and lichenoid graft versus host disease (GvHD). Extracorporeal photopheresis (ECP) therapy has been shown effective in GvHD in several publications; only one study addresses its use in chronic erosive lichen planus.
Four patients with erosive oral lichen planus were treated. Therapy was performed on two consecutive days (therapy cycle) every two weeks. Following clinical improvement, the therapy intervals were prolonged.
In all four patients clinical symptoms and mucosal lesions improved after seven to nine therapy cycles. A temporary worsening occurred in two patients following dental procedures. One of those patients still requires regular ECP therapy. Two patients discontinued therapy following nearly complete remission for other reasons. One patient stopped therapy after 19 cycles of ECP therapy and has remained in complete remission for 9 months. No side effects were seen during treatment.
Extracorporeal photopheresis is an effective therapeutic option for the treatment of erosive oral lichen planus, especially due to the lack of side effects in contrast to other established therapies. Adjunctive topical treatment is also required.
糜烂性口腔扁平苔藓通常对治疗有抵抗性。在组织学和免疫病理学上,扁平苔藓与苔藓样移植物抗宿主病(GvHD)之间存在许多相似之处。体外光化学疗法(ECP)已在多篇出版物中显示对GvHD有效;仅有一项研究探讨了其在慢性糜烂性扁平苔藓中的应用。
对4例糜烂性口腔扁平苔藓患者进行了治疗。每两周连续两天进行治疗(治疗周期)。临床症状改善后,延长治疗间隔时间。
所有4例患者在7至9个治疗周期后临床症状和黏膜病变均有改善。2例患者在牙科手术后出现暂时恶化。其中1例患者仍需定期进行ECP治疗。另外2例患者因其他原因在几乎完全缓解后停止治疗。1例患者在接受19个周期的ECP治疗后停止治疗,目前已完全缓解9个月。治疗期间未见副作用。
体外光化学疗法是治疗糜烂性口腔扁平苔藓的一种有效治疗选择,特别是与其他既定疗法相比,其没有副作用。同时也需要辅助局部治疗。